AAAAAA

   
Results: 1-19 |
Results: 19
Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation
Authors: Aigner, A Juhl, H Malerczyk, C Tkybusch, A Benz, CC Czubayko, F
Citation: A. Aigner et al., Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation, ONCOGENE, 20(17), 2001, pp. 2101-2111
Tumor targeting using anti-her2 immunoliposomes
Authors: Park, JW Kirpotin, DB Hong, K Shalaby, R Shao, Y Nielsen, UB Marks, JD Papahadjopoulos, D Benz, CC
Citation: Jw. Park et al., Tumor targeting using anti-her2 immunoliposomes, J CONTR REL, 74(1-3), 2001, pp. 95-113
Expedition inspiration consensus 2001
Authors: Benz, CC Hilakivi-Clarke, L Conzen, S Dorn, RV Fleming, GF Grant, K Greene, G Hellman, S Henderson, C Hoover, R Hryniuk, W Jeffrey, S Lippman, M Lung, J Mitchell, M Pike, M
Citation: Cc. Benz et al., Expedition inspiration consensus 2001, BREAST CANC, 70(3), 2001, pp. 213-219
Liposome targeting to tumors using vitamin and growth factor receptors
Authors: Drummond, DC Hong, KL Park, JW Benz, CC Kirpotin, DB
Citation: Dc. Drummond et al., Liposome targeting to tumors using vitamin and growth factor receptors, VITAM HORM, 60, 2001, pp. 285-332
Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function
Authors: Neve, RM Nielsen, UB Kirpotin, DB Poul, MA Marks, JD Benz, CC
Citation: Rm. Neve et al., Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function, BIOC BIOP R, 280(1), 2001, pp. 274-279
Ets regulation of the erbB2 promoter
Authors: Scott, GK Chang, CH Erny, KM Xu, F Fredericks, WJ Rauscher, FJ Thor, AD Benz, CC
Citation: Gk. Scott et al., Ets regulation of the erbB2 promoter, ONCOGENE, 19(55), 2000, pp. 6490-6502
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): A study of incidence and correlation with outcome in breast cancer
Authors: Thor, AD Liu, S Edgerton, S Moore, D Kasowitz, KM Benz, CC Stern, DF DiGiovanna, MP
Citation: Ad. Thor et al., Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): A study of incidence and correlation with outcome in breast cancer, J CL ONCOL, 18(18), 2000, pp. 3230-3239
Targeting the Ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides
Authors: Chiang, SY Burli, RW Benz, CC Gawron, L Scott, GK Dervan, PB Beerman, TA
Citation: Sy. Chiang et al., Targeting the Ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides, J BIOL CHEM, 275(32), 2000, pp. 24246-24254
Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily - Role as anticancer agents
Authors: Noonberg, SB Benz, CC
Citation: Sb. Noonberg et Cc. Benz, Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily - Role as anticancer agents, DRUGS, 59(4), 2000, pp. 753-767
Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding
Authors: Whittal, RM Benz, CC Scott, G Semyonov, J Burlingame, AL Baldwin, MA
Citation: Rm. Whittal et al., Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding, BIOCHEM, 39(29), 2000, pp. 8406-8417
Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance
Authors: Johnston, SRD Lu, B Scott, GK Kushner, PJ Smith, IE Dowsett, M Benz, CC
Citation: Srd. Johnston et al., Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance, CLIN CANC R, 5(2), 1999, pp. 251-256
Constitutive expression of Heregulin induces apoptosis in an erbB-2 overexpressing breast cancer cell line SKBr-3
Authors: Guerra-Vladusic, FK Scott, G Weaver, V Vladusic, EA Tsai, MS Benz, CC Lupu, R
Citation: Fk. Guerra-vladusic et al., Constitutive expression of Heregulin induces apoptosis in an erbB-2 overexpressing breast cancer cell line SKBr-3, INT J ONCOL, 15(5), 1999, pp. 883-892
Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX,confers potent transactivating capacity and binds to TATA-binding protein (TBP)
Authors: Chang, CH Scott, GK Baldwin, MA Benz, CC
Citation: Ch. Chang et al., Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX,confers potent transactivating capacity and binds to TATA-binding protein (TBP), ONCOGENE, 18(25), 1999, pp. 3682-3695
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
Authors: Baselga, J Tripathy, D Mendelsohn, J Baughman, S Benz, CC Dantis, L Sklarin, NT Seidman, AD Hudis, CA Moore, J Rosen, PP Twaddell, T Henderson, IC Norton, L
Citation: J. Baselga et al., Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer, SEMIN ONCOL, 26(4), 1999, pp. 78-83
Transcription factors and breast cancer
Authors: Benz, CC
Citation: Cc. Benz, Transcription factors and breast cancer, ENDOCR-R CA, 5(4), 1998, pp. 271-282
Anti-HER2 immunoliposomes for targeted drug delivery
Authors: Park, JW Kirpotin, D Hong, K Colbern, G Shalaby, R Shao, Y Meyer, O Nielsen, U Marks, J Benz, CC Papahadjopoulos, D
Citation: Jw. Park et al., Anti-HER2 immunoliposomes for targeted drug delivery, MED CHEM RE, 8(7-8), 1998, pp. 383-391
Targeting of drugs to solid tumors using anti-HER2 immunoliposomes
Authors: Papahadjopoulos, D Kirpotin, DB Park, JW Hong, KL Shao, Y Shalaby, R Colbern, G Benz, CC
Citation: D. Papahadjopoulos et al., Targeting of drugs to solid tumors using anti-HER2 immunoliposomes, J LIPOS RES, 8(4), 1998, pp. 425-442
Oxidant stress impaired DNA-binding of estrogen receptor from human breastcancer
Authors: Liang, XS Lu, B Scott, GK Chang, CH Baldwin, MA Benz, CC
Citation: Xs. Liang et al., Oxidant stress impaired DNA-binding of estrogen receptor from human breastcancer, MOL C ENDOC, 146(1-2), 1998, pp. 151-161
Targeting of sterically stabilized liposomes to cancers overexpressing HER2/neu proto-oncogene
Authors: Kirpotin, DB Park, JW Hong, KL Shao, Y Colbern, G Zheng, WW Meyer, O Benz, CC Papahadjopoulos, D
Citation: Db. Kirpotin et al., Targeting of sterically stabilized liposomes to cancers overexpressing HER2/neu proto-oncogene, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 325-345
Risultati: 1-19 |